Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says
In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof
FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy
FDA To Regulate Products From Human Cells, Tissue
NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group
In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









